{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:21:59Z","timestamp":1775694119651,"version":"3.50.1"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T00:00:00Z","timestamp":1635897600000},"content-version":"vor","delay-in-days":447,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R35 ES030443"],"award-info":[{"award-number":["R35 ES030443"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10 RR033106"],"award-info":[{"award-number":["S10 RR033106"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL137228"],"award-info":[{"award-number":["R01 HL137228"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL085844"],"award-info":[{"award-number":["R01 HL085844"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL085727"],"award-info":[{"award-number":["R01 HL085727"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R56 HL138392"],"award-info":[{"award-number":["R56 HL138392"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DC015135"],"award-info":[{"award-number":["R01 DC015135"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 AG051443"],"award-info":[{"award-number":["P01 AG051443"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K99R00 ES024806"],"award-info":[{"award-number":["K99R00 ES024806"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Stem cell replacement offers a great potential for cardiac regenerative therapy. However, one of the critical barriers to stem cell therapy is a significant loss of transplanted stem cells from ischemia and inflammation in the host environment. Here, we tested the hypothesis that inhibition of the soluble epoxide hydrolase (sEH) enzyme using sEH inhibitors (sEHIs) to decrease inflammation and fibrosis in the host myocardium may increase the survival of the transplanted human induced pluripotent stem cell derived-cardiomyocytes (hiPSC-CMs) in a murine postmyocardial infarction model. A specific sEHI (1-trifluoromethoxyphenyl-3-(1-propionylpiperidine-4-yl)urea [TPPU]) and CRISPR\/Cas9 gene editing were used to test the hypothesis. TPPU results in a significant increase in the retention of transplanted cells compared with cell treatment alone. The increase in the retention of hiPSC-CMs translates into an improvement in the fractional shortening and a decrease in adverse remodeling. Mechanistically, we demonstrate a significant decrease in oxidative stress and apoptosis not only in transplanted hiPSC-CMs but also in the host environment. CRISPR\/Cas9-mediated gene silencing of the sEH enzyme reduces cleaved caspase-3 in hiPSC-CMs challenged with angiotensin II, suggesting that knockdown of the sEH enzyme protects the hiPSC-CMs from undergoing apoptosis. Our findings demonstrate that suppression of inflammation and fibrosis using an sEHI represents a promising adjuvant to cardiac stem cell-based therapy. Very little is known regarding the role of this class of compounds in stem cell-based therapy. There is consequently an enormous opportunity to uncover a potentially powerful class of compounds, which may be used effectively in the clinical setting.<\/jats:p>\n               <jats:sec>\n                  <jats:title\/>\n                  <jats:p>Significance statement Stem cell replacement offers a great potential for cardiac regenerative therapy. However, there is a significant loss of transplanted stem cells from ischemia and inflammation in the host environment. This study demonstrates beneficial effects of inhibitors of soluble epoxide hydrolase (sEHI) in cell-based therapy using human induced pluripotent stem cell-derived cardiomyocytes in a preclinical model. sEHI results in a significant increase in the retention of transplanted stem cells and an improvement in cardiac function. Very little is known regarding this class of compounds in cell-based therapy. There is consequently an opportunity to uncover a potentially powerful class of inhibitors, which may be used in clinical settings.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1002\/sctm.20-0143","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T13:57:59Z","timestamp":1597327079000},"page":"1570-1584","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Suppression of inflammation and fibrosis using soluble epoxide hydrolase inhibitors enhances cardiac stem cell-based therapy"],"prefix":"10.1093","volume":"9","author":[{"given":"Padmini","family":"Sirish","sequence":"first","affiliation":[{"name":"1 Division of Cardiovascular Medicine University of California, Davis, California, USA"},{"name":"2 Department of Veterans Affairs Northern California Health Care System, Mather, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phung N.","family":"Thai","sequence":"additional","affiliation":[{"name":"1 Division of Cardiovascular Medicine University of California, Davis, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Han","family":"Lee","sequence":"additional","affiliation":[{"name":"3 Department of Physiology and Cell Biology University of Nevada, Reno, Reno, Nevada, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[{"name":"4 Department of Entomology and Nematology and Comprehensive Cancer Center University of California, Davis, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Dong","family":"Zhang","sequence":"additional","affiliation":[{"name":"1 Division of Cardiovascular Medicine University of California, Davis, California, USA"},{"name":"2 Department of Veterans Affairs Northern California Health Care System, Mather, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Ren","sequence":"additional","affiliation":[{"name":"1 Division of Cardiovascular Medicine University of California, Davis, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[{"name":"1 Division of Cardiovascular Medicine University of California, Davis, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeriy","family":"Timofeyev","sequence":"additional","affiliation":[{"name":"1 Division of Cardiovascular Medicine University of California, Davis, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kin Sing Stephen","family":"Lee","sequence":"additional","affiliation":[{"name":"4 Department of Entomology and Nematology and Comprehensive Cancer Center University of California, Davis, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol E.","family":"Nader","sequence":"additional","affiliation":[{"name":"1 Division of Cardiovascular Medicine University of California, Davis, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas J.","family":"Rowland","sequence":"additional","affiliation":[{"name":"5 Center for Molecular and Genomic Imaging University of California, Davis, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey","family":"Yechikov","sequence":"additional","affiliation":[{"name":"1 Division of Cardiovascular Medicine University of California, Davis, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana","family":"Ganaga","sequence":"additional","affiliation":[{"name":"6 Department of Surgery University of California, Davis, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilas","family":"Young","sequence":"additional","affiliation":[{"name":"6 Department of Surgery University of California, Davis, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah K.","family":"Lieu","sequence":"additional","affiliation":[{"name":"1 Division of Cardiovascular Medicine University of California, Davis, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebenezer N.","family":"Yamoah","sequence":"additional","affiliation":[{"name":"3 Department of Physiology and Cell Biology University of Nevada, Reno, Reno, Nevada, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce D.","family":"Hammock","sequence":"additional","affiliation":[{"name":"4 Department of Entomology and Nematology and Comprehensive Cancer Center University of California, Davis, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nipavan","family":"Chiamvimonvat","sequence":"additional","affiliation":[{"name":"1 Division of Cardiovascular Medicine University of California, Davis, California, USA"},{"name":"2 Department of Veterans Affairs Northern California Health Care System, Mather, California, USA"},{"name":"7 Department of Pharmacology University of California, Davis, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,8,13]]},"reference":[{"key":"2022022809522649900_sct312789-bib-0001","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"N Engl J Med"},{"key":"2022022809522649900_sct312789-bib-0002","doi-asserted-by":"crossref","first-page":"6A","DOI":"10.1016\/0735-1097(93)90455-A","article-title":"The epidemiology of heart failure: the Framingham Study","volume":"22","author":"Ho","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"2022022809522649900_sct312789-bib-0003","first-page":"801","article-title":"Trends of congestive heart failure epidemiology: contrast with clinical trial results","volume":"44","author":"Dominguez","year":"1999","journal-title":"Cardiologia"},{"key":"2022022809522649900_sct312789-bib-0004","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJM198606123142404","article-title":"Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a veterans administration cooperative study","volume":"314","author":"Cohn","year":"1986","journal-title":"N Engl J Med"},{"key":"2022022809522649900_sct312789-bib-0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.carpath.2015.02.004","article-title":"The winding road to regenerating the human heart","volume":"24","author":"Gerbin","year":"2015","journal-title":"Cardiovasc Pathol"},{"key":"2022022809522649900_sct312789-bib-0006","first-page":"e38","article-title":"Heart disease and stroke statistics-2016 update: a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"2022022809522649900_sct312789-bib-0007","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1161\/CIRCRESAHA.114.300556","article-title":"Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges","volume":"114","author":"Lalit","year":"2014","journal-title":"Circ Res"},{"key":"2022022809522649900_sct312789-bib-0008","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/01.RES.0000155333.69009.63","article-title":"Clinical applications of stem cells for the heart","volume":"96","author":"Kai","year":"2005","journal-title":"Circ Res"},{"key":"2022022809522649900_sct312789-bib-0009","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1038\/s41467-019-11091-2","article-title":"Dual stem cell therapy synergistically improves cardiac function and vascular regeneration following myocardial infarction","volume":"10","author":"Park","year":"2019","journal-title":"Nat Commun"},{"key":"2022022809522649900_sct312789-bib-0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000187652","article-title":"Cell therapy of acute myocardial infarction: open questions","volume":"113","author":"Dimmeler","year":"2009","journal-title":"Cardiology"},{"key":"2022022809522649900_sct312789-bib-0011","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1161\/CIRCRESAHA.111.255570","article-title":"Stem cells review series: an introduction","volume":"109","author":"Dimmeler","year":"2011","journal-title":"Circ Res"},{"key":"2022022809522649900_sct312789-bib-0012","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nbt1327","article-title":"Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts","volume":"25","author":"Laflamme","year":"2007","journal-title":"Nat Biotechnol"},{"key":"2022022809522649900_sct312789-bib-0013","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/CIRCULATIONAHA.109.916338","article-title":"Cardiovascular molecular imaging: focus on clinical translation","volume":"123","author":"Chen","year":"2011","journal-title":"Circulation"},{"key":"2022022809522649900_sct312789-bib-0014","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s12265-011-9281-3","article-title":"Imaging cardiac stem cell therapy: translations to human clinical studies","volume":"4","author":"Zhang","year":"2011","journal-title":"J Cardiovasc Transl Res"},{"key":"2022022809522649900_sct312789-bib-0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0163-7827(03)00049-3","article-title":"Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function","volume":"43","author":"Spector","year":"2004","journal-title":"Prog Lipid Res"},{"key":"2022022809522649900_sct312789-bib-0016","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev.pharmtox.45.120403.095920","article-title":"Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles","volume":"45","author":"Morisseau","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2022022809522649900_sct312789-bib-0017","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1073\/pnas.1221972110","article-title":"Unique mechanistic insights into the beneficial effects of soluble epoxide hydrolase inhibitors in the prevention of cardiac fibrosis","volume":"110","author":"Sirish","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022022809522649900_sct312789-bib-0018","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/FJC.0b013e3181506445","article-title":"The soluble epoxide hydrolase as a pharmaceutical target for hypertension","volume":"50","author":"Chiamvimonvat","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"2022022809522649900_sct312789-bib-0019","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1751-7133.2010.00209.x","article-title":"Use of metabolomic profiling in the study of arachidonic acid metabolism in cardiovascular disease","volume":"17","author":"Li","year":"2011","journal-title":"Congest Heart Fail"},{"key":"2022022809522649900_sct312789-bib-0020","doi-asserted-by":"crossref","first-page":"18402","DOI":"10.1073\/pnas.0908207106","article-title":"Alpha-actinin2 cytoskeletal protein is required for the functional membrane localization of a Ca2+-activated K+ channel (SK2 channel)","volume":"106","author":"Lu","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022022809522649900_sct312789-bib-0021","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.115.003721","article-title":"Molecular mechanisms and new treatment paradigm for atrial fibrillation","volume":"9","author":"Sirish","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022022809522649900_sct312789-bib-0022","doi-asserted-by":"crossref","first-page":"15265","DOI":"10.1074\/jbc.M000278200","article-title":"Binding of alkylurea inhibitors to epoxide hydrolase implicates active site tyrosines in substrate activation","volume":"275","author":"Argiriadi","year":"2000","journal-title":"J Biol Chem"},{"key":"2022022809522649900_sct312789-bib-0023","doi-asserted-by":"crossref","first-page":"10637","DOI":"10.1073\/pnas.96.19.10637","article-title":"Detoxification of environmental mutagens and carcinogens: structure, mechanism, and evolution of liver epoxide hydrolase","volume":"96","author":"Argiriadi","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022022809522649900_sct312789-bib-0024","doi-asserted-by":"crossref","first-page":"8849","DOI":"10.1073\/pnas.96.16.8849","article-title":"Potent urea and carbamate inhibitors of soluble epoxide hydrolases","volume":"96","author":"Morisseau","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022022809522649900_sct312789-bib-0025","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/j.1476-5381.2011.01641.x","article-title":"Pharmacokinetics and in vivo potency of soluble epoxide hydrolase inhibitors in cynomolgus monkeys","volume":"165","author":"Ulu","year":"2012","journal-title":"Br J Pharmacol"},{"key":"2022022809522649900_sct312789-bib-0026","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ejps.2012.12.013","article-title":"Substituted phenyl groups improve the pharmacokinetic profile and anti-inflammatory effect of urea-based soluble epoxide hydrolase inhibitors in murine models","volume":"48","author":"Liu","year":"2013","journal-title":"Eur J Pharm Sci"},{"key":"2022022809522649900_sct312789-bib-0027","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1021\/bi036189j","article-title":"Structure of human epoxide hydrolase reveals mechanistic inferences on bifunctional catalysis in epoxide and phosphate ester hydrolysis","volume":"43","author":"Gomez","year":"2004","journal-title":"Biochemistry"},{"key":"2022022809522649900_sct312789-bib-0028","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1110\/ps.051720206","article-title":"Human soluble epoxide hydrolase: structural basis of inhibition by 4-(3-cyclohexylureido)-carboxylic acids","volume":"15","author":"Gomez","year":"2006","journal-title":"Protein Sci"},{"key":"2022022809522649900_sct312789-bib-0029","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.chemosphere.2010.11.048","article-title":"Insights into the structure of urea-like compounds as inhibitors of the juvenile hormone epoxide hydrolase (JHEH) of the tobacco hornworm Manduca sexta: analysis of the binding modes and structure-activity relationships of the inhibitors by docking and CoMFA calculations","volume":"82","author":"Garriga","year":"2011","journal-title":"Chemosphere"},{"key":"2022022809522649900_sct312789-bib-0030","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1021\/jm101382t","article-title":"Discovery of potent inhibitors of soluble epoxide hydrolase by combinatorial library design and structure-based virtual screening","volume":"54","author":"Xing","year":"2011","journal-title":"J Med Chem"},{"key":"2022022809522649900_sct312789-bib-0031","doi-asserted-by":"crossref","first-page":"6762","DOI":"10.1016\/j.bmcl.2012.08.066","article-title":"Evaluation of structure-derived pharmacophore of soluble epoxide hydrolase inhibitors by virtual screening","volume":"22","author":"Moser","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"2022022809522649900_sct312789-bib-0032","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.bmc.2014.03.001","article-title":"Structural insights into binding of inhibitors to soluble epoxide hydrolase gained by fragment screening and X-ray crystallography","volume":"22","author":"Amano","year":"2014","journal-title":"Bioorg Med Chem"},{"key":"2022022809522649900_sct312789-bib-0033","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.bmcl.2015.02.076","article-title":"Three-dimensional rational approach to the discovery of potent substituted cyclopropyl urea soluble epoxide hydrolase inhibitors","volume":"25","author":"Takai","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"2022022809522649900_sct312789-bib-0034","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.bmc.2015.03.083","article-title":"Identification of N-ethylmethylamine as a novel scaffold for inhibitors of soluble epoxide hydrolase by crystallographic fragment screening","volume":"23","author":"Amano","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"2022022809522649900_sct312789-bib-0035","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1021\/jm070270t","article-title":"Orally bioavailable potent soluble epoxide hydrolase inhibitors","volume":"50","author":"Hwang","year":"2007","journal-title":"J Med Chem"},{"key":"2022022809522649900_sct312789-bib-0036","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-1-61779-145-1_7","article-title":"Imaging of embryonic stem cell migration in vivo","volume":"750","author":"Lee","year":"2011","journal-title":"Methods Mol Biol"},{"key":"2022022809522649900_sct312789-bib-0037","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nprot.2012.150","article-title":"Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt\/beta-catenin signaling under fully defined conditions","volume":"8","author":"Lian","year":"2013","journal-title":"Nat Protoc"},{"key":"2022022809522649900_sct312789-bib-0038","doi-asserted-by":"crossref","first-page":"E1848","DOI":"10.1073\/pnas.1200250109","article-title":"Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling","volume":"109","author":"Lian","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022022809522649900_sct312789-bib-0039","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.yjmcc.2005.09.001","article-title":"Transplantation of embryonic stem cells into the infarcted mouse heart: formation of multiple cell types","volume":"40","author":"Singla","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"2022022809522649900_sct312789-bib-0040","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11897-017-0343-y","article-title":"From inflammation to fibrosis-molecular and cellular mechanisms of myocardial tissue remodelling and perspectives on differential treatment opportunities","volume":"14","author":"Suthahar","year":"2017","journal-title":"Curr Heart Fail Rep"},{"key":"2022022809522649900_sct312789-bib-0041","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"2022022809522649900_sct312789-bib-0042","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4252\/wjsc.v9.i1.9","article-title":"Optimizing stem cells for cardiac repair: current status and new frontiers in regenerative cardiology","volume":"9","author":"Der Sarkissian","year":"2017","journal-title":"World J Stem Cells"},{"key":"2022022809522649900_sct312789-bib-0043","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/jcmm.12147","article-title":"Improving survival and efficacy of pluripotent stem cell-derived cardiac grafts","volume":"17","author":"Don","year":"2013","journal-title":"J Cell Mol Med"},{"key":"2022022809522649900_sct312789-bib-0044","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbrc.2008.09.004","article-title":"Improving outcome of transplanted mesenchymal stem cells for ischemic heart disease","volume":"376","author":"Shi","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"2022022809522649900_sct312789-bib-0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.stem.2014.06.009","article-title":"Immune modulation of stem cells and regeneration","volume":"15","author":"Aurora","year":"2014","journal-title":"Cell Stem Cell"},{"key":"2022022809522649900_sct312789-bib-0046","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1161\/CIRCULATIONAHA.109.865956","article-title":"Survival and cardiac remodeling after myocardial infarction are critically dependent on the host innate immune interleukin-1 receptor-associated kinase-4 signaling: a regulator of bone marrow-derived dendritic cells","volume":"120","author":"Maekawa","year":"2009","journal-title":"Circulation"},{"key":"2022022809522649900_sct312789-bib-0047","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.3727\/096368912X639035","article-title":"Production of reactive oxygen species by multipotent stromal cells\/mesenchymal stem cells upon exposure to fas ligand","volume":"21","author":"Rodrigues","year":"2012","journal-title":"Cell Transplant"},{"key":"2022022809522649900_sct312789-bib-0048","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1172\/JCI200524408","article-title":"Oxygen, oxidative stress, hypoxia, and heart failure","volume":"115","author":"Giordano","year":"2005","journal-title":"J Clin Invest"},{"key":"2022022809522649900_sct312789-bib-0049","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.stem.2014.11.009","article-title":"Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells","volume":"15","author":"Ye","year":"2014","journal-title":"Cell Stem Cell"},{"key":"2022022809522649900_sct312789-bib-0050","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.yjmcc.2008.03.009","article-title":"Systems approaches to preventing transplanted cell death in cardiac repair","volume":"45","author":"Robey","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"2022022809522649900_sct312789-bib-0051","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1073\/pnas.0811022106","article-title":"Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy","volume":"106","author":"Ai","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022022809522649900_sct312789-bib-0052","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1751-7133.2008.08430.x","article-title":"The potential of soluble epoxide hydrolase inhibition in the treatment of cardiac hypertrophy","volume":"14","author":"Harris","year":"2008","journal-title":"Congest Heart Fail"},{"key":"2022022809522649900_sct312789-bib-0053","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.yjmcc.2009.08.017","article-title":"Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: insight gained using metabolomic approaches","volume":"47","author":"Li","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"2022022809522649900_sct312789-bib-0054","doi-asserted-by":"crossref","first-page":"17017","DOI":"10.1073\/pnas.1011278107","article-title":"Metabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxib-mediated cardiovascular events","volume":"107","author":"Liu","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022022809522649900_sct312789-bib-0055","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.bcp.2009.10.025","article-title":"Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model","volume":"79","author":"Liu","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"2022022809522649900_sct312789-bib-0056","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1755-5922.2010.00150.x","article-title":"Soluble epoxide hydrolase inhibitors and heart failure","volume":"29","author":"Qiu","year":"2011","journal-title":"Cardiovasc Ther"},{"key":"2022022809522649900_sct312789-bib-0057","doi-asserted-by":"crossref","first-page":"18733","DOI":"10.1073\/pnas.0609158103","article-title":"Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors","volume":"103","author":"Xu","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022022809522649900_sct312789-bib-0058","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/CIRCRESAHA.109.210682","article-title":"Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice","volume":"106","author":"Chimenti","year":"2010","journal-title":"Circ Res"}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fsctm.20-0143","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/sctm.20-0143","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/sctm.20-0143","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/9\/12\/1570\/42629569\/stcltm_9_12_1570.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/9\/12\/1570\/42629569\/stcltm_9_12_1570.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T10:08:00Z","timestamp":1646042880000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/9\/12\/1570\/6407029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,13]]},"references-count":58,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,8,13]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/sctm.20-0143","relation":{},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12,1]]},"published":{"date-parts":[[2020,8,13]]},"assertion":[{"value":"2020-04-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}